- €50.68m
- €97.72m
- €98.73m
- 33
- 47
- 35
- 27
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 19.16 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | 0.64% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.64 | ||
| Price to Tang. Book | 0.76 | ||
| Price to Free Cashflow | 35.74 | ||
| Price to Sales | 0.53 | ||
| EV to EBITDA | 28.78 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -8.02% | ||
| Return on Equity | -15.06% | ||
| Operating Margin | -10.2% | ||
Financial Summary
| Year End 30th Sep | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 93.88 | 115.17 | 116.09 | 106.34 | 98.73 | 102.8 | 113.15 | -1.73% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -53.06 | n/a | n/a | n/a | n/a | n/a | +590 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Dr. Hoenle AG is a Germany-based company. The Company is engaged in three business units (BU): Adhesive Systems, Curing and Disinfection. The Adhesive Systems BU supplies industrial adhesives and Ultra-Violet (UV) light curing equipment for the electronics, medical technology, optics, and automotive sectors. The Curing BU sells equipment and installations for curing paints and coatings, these systems facilitate printers (particularly packaging printers), in surface coatings for floor coverings, in the furniture industry, in the automotive industry and in other industrial coating applications. It also offers lifecycle solutions. The Disinfection BU combines the business activities in the areas of water, surface, and air disinfection. The Disinfection segment also offers services such as microbiological analysis in addition to UV lamps and components. The Company operates globally with around 20 subsidiaries.
Directors
- Karl Hoenle CSU
- Gunther Henrich VSU (75)
- Norbert Haimerl FID (59)
- Rainer Pumpe CTO (54)
- Heiko Runge MDR (57)
- Bernhard Gimple IND
- Imke Libon SUB
- Last Annual
- September 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 21st, 1999
- Public Since
- February 25th, 2008
- No. of Employees
- 585
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
XETRA- Shares in Issue
- 6,061,854
- Address
- Nicolaus-Otto-Str. 2, GILCHING, 82205
- Web
- https://www.hoenle.de/
- Phone
- +49 810520830
- Contact
- Peter Weinert
- Auditors
- RSM Ebner Stolz GmbH & Co. KG
Upcoming Events for HNL
Dr Hoenle AG at Berenberg and Goldman Sachs German Corporate Conference
Similar to HNL
FAQ
What is the Dr Hoenle AG share price?
As of Today at 20:19 UTC, shares in Dr Hoenle AG are trading at €8.36. This share price information is delayed by 15 minutes.
How has the Dr Hoenle AG share price performed this year?
Shares in Dr Hoenle AG last closed at €8.36 and the price had moved by -57.99% over the past 365 days. In terms of relative price strength the Dr Hoenle AG share price has underperformed the FTSE Global All Cap Index by -59.04% over the past year.
What are the analyst and broker recommendations for Dr Hoenle AG?
The overall consensus recommendation for Dr Hoenle AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Dr Hoenle AG dividend yield?
Dr Hoenle AG does not currently pay a dividend.
Does Dr Hoenle AG pay a dividend?
Dr Hoenle AG does not currently pay a dividend.
When does Dr Hoenle AG next pay dividends?
Dr Hoenle AG does not currently pay a dividend.
How do I buy Dr Hoenle AG shares?
To buy shares in Dr Hoenle AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Dr Hoenle AG?
As of the previous close price of €8.36, shares in Dr Hoenle AG had a market capitalisation of €50.68m.
Where are Dr Hoenle AG shares listed?
Here are the trading details for Dr Hoenle AG:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: HNL
What kind of share is Dr Hoenle AG?
Based on an overall assessment of its quality, value and momentum Dr Hoenle AG is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Dr Hoenle AG share price forecast for 2025?
The analyst consensus target price for shares in Dr Hoenle AG is €19.50. That is 133.25% above the last closing price of €8.36.
Analysts covering Dr Hoenle AG currently have a consensus Earnings Per Share (EPS) forecast of €0.10 for the next financial year.
Find out moreWhat is the trend in the Dr Hoenle AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Dr Hoenle AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -16.92%.
As of the last closing price of €8.36, shares in Dr Hoenle AG were trading -22.86% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Dr Hoenle AG PE Ratio?
The Dr Hoenle AG PE ratio based on its reported earnings over the past 12 months is 19.16. The shares last closed at €8.36.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Dr Hoenle AG?
Dr Hoenle AG's management team is headed by:
- Karl Hoenle - CSU
- Gunther Henrich - VSU
- Norbert Haimerl - FID
- Rainer Pumpe - CTO
- Heiko Runge - MDR
- Bernhard Gimple - IND
- Imke Libon - SUB